Famciclovir treatment of hepatitis B virus recurrence after liver transplantation: A pilot study
Martin Krüger, Hans Ludger Tillmann, Christian Trautwein, Ulrike Bode, Karl Oldhafer, Hansjörg Maschek, Klaus H. W. Böker, Christoph E. Broelsch, Rudolf Pichlmayr, Michael P. Manns – 1 July 1996 – Despite hepatitis B immunoprophylaxis hepatitis B virus (HBV) recurrence is a frequent and often fatal complication after orthotopic liver transplantation (OLT). The purine nucleoside analogues penciclovir and its oral form famciclovir (FCV) proved to be well tolerated and effective against herpes simplex and zoster virus infections.